Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jun 19, 2014 |
referred to higher education returned to assembly repassed senate |
Jun 16, 2014 |
amended on third reading (t) 7125a |
Jun 16, 2014 |
vote reconsidered - restored to third reading returned to senate recalled from assembly |
Jun 09, 2014 |
referred to higher education delivered to assembly passed senate |
Jun 03, 2014 |
ordered to third reading cal.1126 committee discharged and committed to rules |
Apr 30, 2014 |
referred to health |
Senate Bill S7125
2013-2014 Legislative Session
Sponsored By
(R, C, IP) Senate District
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
(D) Senate District
2013-S7125 - Details
2013-S7125 - Sponsor Memo
BILL NUMBER:S7125 TITLE OF BILL: An act to amend the public health law, in relation to the use of abuse-deterrent technology for analgesic opioids as a mechanism for reducing abuse and diversion of opioid drugs. PURPOSE OR GENERAL IDEA OF BILL: To help prevent the abuse and diversion of opioid analgesic drugs by ensuring that opioid analgesic drugs which incorporate abuse-deterrent technologies are dispensed whenever possible. SUMMARY OF SPECIFIC PROVISIONS: Section 1 adds a new section 3340 to the Public health law to prohibit the substitution of opioids which have abuse-deterrent technologies with those which do not have such abuse-deterrent technologies without the consent of the prescribing physician. Section 2 is the effective date of the bill. JUSTIFICATION: While pain management is an important and integral part of the health care system, abuse and diversion of opioids has necessitated the implementation of anti-abuse policies. These policies need to be
2013-S7125 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7125 I N S E N A T E April 30, 2014 ___________ Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to the use of abuse- deterrent technology for analgesic opioids as a mechanism for reducing abuse and diversion of opioid drugs. THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 3340 to read as follows: S 3340. SUBSTITUTION OF OPIOIDS WITH ABUSE-DETERRENT TECHNOLOGY. 1. NOTWITHSTANDING THE PROVISIONS OF SECTION SIXTY-EIGHT HUNDRED SIXTEEN-A OF THE EDUCATION LAW, NO PHARMACIST SHALL INTERCHANGE OR SUBSTITUTE AN OPIOID ANALGESIC DRUG, BRAND OR GENERIC, OTHERWISE ELIGIBLE FOR SUCH INTERCHANGE OR SUBSTITUTION UNDER SUCH SECTION FOR AN OPIOID ANALGESIC DRUG INCORPORATING ABUSE-DETERRENT TECHNOLOGY WITHOUT: (A) VERIFYING THAT THE DRUG TO BE SUBSTITUTED IS AN OPIOID ANALGESIC DRUG INCORPORATING ABUSE-DETERRENT TECHNOLOGY WITH THE SAME DEGREE (TIER) OF FEDERAL FOOD AND DRUG ADMINISTRATION APPROVED LABELING CLAIM RELATED TO ABUSE DETERRENCE AS THE PRESCRIBED OPIOID ANALGESIC DRUG; OR (B) OBTAINING WRITTEN, SIGNED CONSENT FROM THE PRESCRIBING PHYSICIAN FOR SUCH INTERCHANGE OR SUBSTITUTION. 2. A PRESCRIPTION SHALL NOT BE ISSUED OR FILLED FOR ANY OPIOID ANAL- GESIC DRUG THAT IS FORMULATED AS A NON-ABUSE DETERRENT OPIOID DRUG, UNLESS AN OPIOID ANALGESIC DRUG INCORPORATING ABUSE-DETERRENT TECHNOLOGY IS NOT AVAILABLE AS A SUBSTITUTE FOR THE INDICATED DRUG OR SUBSTANCE. 3. DEFINITIONS. AS USED IN THIS SECTION: (A) "OPIOID ANALGESIC DRUG" MEANS A DRUG IN THE OPIOID ANALGESIC DRUG CLASS PRESCRIBED TO TREAT MODERATE TO SEVERE PAIN OR OTHER CONDITIONS, WHETHER IN IMMEDIATE RELEASE OR EXTENDED RELEASE FORM AND WHETHER OR NOT COMBINED WITH OTHER DRUG SUBSTANCES TO FORM A SINGLE TABLET OR OTHER DOSAGE FORM. (B) "OPIOID ANALGESIC DRUG INCORPORATING ABUSE-DETERRENT TECHNOLOGY" MEANS AN OPIOID ANALGESIC DRUG APPROVED AS SUCH BY THE FEDERAL FOOD AND DRUG ADMINISTRATION WITH LABELING CLAIMS RELATED TO ABUSE-DETERRENCE EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
co-Sponsors
(D) Senate District
2013-S7125A (ACTIVE) - Details
2013-S7125A (ACTIVE) - Sponsor Memo
BILL NUMBER:S7125A TITLE OF BILL: An act to amend the public health law, in relation to the use of abuse-deterrent technology for opioids as a mechanism for reducing abuse and diversion of opioid drugs PURPOSE OR GENERAL IDEA OF BILL: To help prevent the abuse and diversion of opioid drugs by ensuring that opioid drugs which incorporate abuse-deterrent technologies are dispensed whenever possible. SUMMARY OF SPECIFIC PROVISIONS: Section 1 adds a new section 3340 to the Public health law to prohibit the substitution of opioids which have abuse-deterrent technologies with those which do not have such abuse-deterrent technologies without the consent of the prescribing physician. Section 2 is the effective date of the bill. JUSTIFICATION: While pain management is an important and integral part of the health care system, abuse and diversion of opioids has necessitated the implementation of anti-abuse policies. These policies need to be approached comprehensively by government, law enforcement, health care providers and manufacturers and an important component is to ensure that opioids incorporating abuse-deterrent technologies are dispensed whenever possible.
2013-S7125A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7125--A Cal. No. 1126 I N S E N A T E April 30, 2014 ___________ Introduced by Sens. HANNON, GIPSON -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- commit- tee discharged and said bill committed to the Committee on Rules -- reported favorably from said committee, ordered to a third reading, passed by Senate and delivered to the Assembly, recalled, vote recon- sidered, restored to third reading, amended and ordered reprinted, retaining its place in the order of third reading AN ACT to amend the public health law, in relation to the use of abuse- deterrent technology for opioids as a mechanism for reducing abuse and diversion of opioid drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 3340 to read as follows: S 3340. SUBSTITUTION OF OPIOIDS WITH ABUSE-DETERRENT TECHNOLOGY. 1. NOTWITHSTANDING THE PROVISIONS OF SECTION SIXTY-EIGHT HUNDRED SIXTEEN-A OF THE EDUCATION LAW, NO PHARMACIST SHALL INTERCHANGE OR SUBSTITUTE AN OPIOID DRUG, BRAND OR GENERIC, OTHERWISE ELIGIBLE FOR SUCH INTERCHANGE OR SUBSTITUTION UNDER SUCH SECTION FOR AN OPIOID DRUG INCORPORATING ABUSE-DETERRENT TECHNOLOGY WITHOUT: (A) VERIFYING THAT THE DRUG TO BE SUBSTITUTED IS AN OPIOID DRUG INCOR- PORATING ABUSE-DETERRENT TECHNOLOGY WITH THE SAME DEGREE (TIER) OF FEDERAL FOOD AND DRUG ADMINISTRATION APPROVED LABELING CLAIM RELATED TO ABUSE DETERRENCE AS THE PRESCRIBED OPIOID DRUG; OR (B) OBTAINING WRITTEN, SIGNED CONSENT FROM THE PRESCRIBING PHYSICIAN FOR SUCH INTERCHANGE OR SUBSTITUTION. 2. A PRESCRIPTION SHALL NOT BE ISSUED OR FILLED FOR ANY OPIOID DRUG THAT IS FORMULATED AS A NON-ABUSE DETERRENT OPIOID DRUG, UNLESS AN OPIOID DRUG INCORPORATING ABUSE-DETERRENT TECHNOLOGY IS NOT AVAILABLE AS A SUBSTITUTE FOR THE INDICATED DRUG OR SUBSTANCE. 3. DEFINITIONS. AS USED IN THIS SECTION: (A) "OPIOID DRUG" MEANS A DRUG IN THE OPIOID DRUG CLASS PRESCRIBED TO TREAT MODERATE TO SEVERE PAIN OR OTHER CONDITIONS, WHETHER IN IMMEDIATE EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.